ArticleIBRO neuroscience reports2026
Blood-brain barrier junctional proteins as potential biomarkers of cerebral ischaemia and reperfusion injury.
Article in IBRO neuroscience reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Cerebral ischaemia/reperfusion (CI/R) damage involves obstructing the blood supply to the brain, followed by restoring cerebral circulation through thrombolytic treatment. The blood-brain barrier (BBB) is a specialised structure separating the brain from peripheral blood circulation and plays an important role in brain function. However, little is known about CI/R-induced BBB damage and changes in circulatory biomarkers. Methods and results: This novel study aims to examine the changes in BBB tight-junctional (TJ) proteins (Zonula occludens-1, Occludin and Claudin-5) in the hippocampus of the brain and determine the levels of these proteins in a mouse model of CI/R induced by bilateral common carotid occlusion. Expressions of BBB TJ proteins in the hippocampus were examined by immunohistochemistry and Western blotting. The levels of these proteins in blood serum were measured by Enzyme-Linked Immunosorbent Assay. Conclusion: The results showed a significant decrease in BBB TJ proteins in the hippocampus, with increased levels of these proteins in blood serum in ischaemic mice as compared to sham-operated mice suggesting that these proteins can be used as potential biomarkers for the diagnosis of CI/R injury.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.